These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25745774)

  • 21. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
    Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
    Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphiphilic dextran-graft-poly(epsilon-caprolactone) films for the controlled release of paclitaxel.
    Shi R; Burt HM
    Int J Pharm; 2004 Mar; 271(1-2):167-79. PubMed ID: 15129983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functionalized nanospheres for targeted delivery of paclitaxel.
    Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
    J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polysorbate 80 coated poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) micelles for paclitaxel delivery.
    Wang Y; Wang C; Gong C; Wang Y; Guo G; Luo F; Qian Z
    Int J Pharm; 2012 Sep; 434(1-2):1-8. PubMed ID: 22609127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
    Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
    J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments of paclitaxel with poly(vinyl pyrrolidone) to improve drug release from poly(ɛ-caprolactone) matrix for film-based stent.
    Lu F; Shen YY; Shen YQ; Hou JW; Wang ZM; Guo SR
    Int J Pharm; 2012 Sep; 434(1-2):161-8. PubMed ID: 22643225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new generation of poly(lactide/ε-caprolactone) polymeric biomaterials for application in the medical field.
    Fernández J; Larrañaga A; Etxeberria A; Wang W; Sarasua JR
    J Biomed Mater Res A; 2014 Oct; 102(10):3573-84. PubMed ID: 24243562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled delivery of paclitaxel from stent coatings using poly(hydroxystyrene-b-isobutylene-b-hydroxystyrene) and its acetylated derivative.
    Sipos L; Som A; Faust R; Richard R; Schwarz M; Ranade S; Boden M; Chan K
    Biomacromolecules; 2005; 6(5):2570-82. PubMed ID: 16153094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of amphiphilic chitosan-g-poly(ε-caprolactone) polymer additives on paclitaxel release from drug eluting implants.
    Shi W; Gu C; Jiang H; Zhang M; Lang M
    Mater Sci Eng C Mater Biol Appl; 2014 Dec; 45():502-9. PubMed ID: 25491857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel poly(L-lactide-co-ε-caprolactone) matrices obtained with the use of Zr[Acac]₄ as nontoxic initiator for long-term release of immunosuppressive drugs.
    Jelonek K; Kasperczyk J; Li S; Dobrzynski P; Janeczek H; Jarzabek B
    Biomed Res Int; 2013; 2013():607351. PubMed ID: 24286081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
    Xu S; Wang W; Li X; Liu J; Dong A; Deng L
    Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
    Letchford K; Liggins R; Wasan KM; Burt H
    Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of star-shaped poly(ϵ-caprolactone)-poly(2-hydroxyethyl methacrylate) as potential anticancer drug delivery carriers.
    Li C; Wang B; Liu Y; Cao J; Feng T; Chen Y; Luo X
    J Biomater Sci Polym Ed; 2013; 24(6):741-57. PubMed ID: 23565913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(epsilon-caprolactone) stent cuff.
    Pires NM; van der Hoeven BL; de Vries MR; Havekes LM; van Vlijmen BJ; Hennink WE; Quax PH; Jukema JW
    Biomaterials; 2005 Sep; 26(26):5386-94. PubMed ID: 15814137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and characterization of the paclitaxel/MPEG-PLA block copolymer conjugate.
    Zhang X; Li Y; Chen X; Wang X; Xu X; Liang Q; Hu J; Jing X
    Biomaterials; 2005 May; 26(14):2121-8. PubMed ID: 15576187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(epsilon-caprolactone) as drug carriers with enhanced properties.
    Zhang W; Li Y; Liu L; Sun Q; Shuai X; Zhu W; Chen Y
    Biomacromolecules; 2010 May; 11(5):1331-8. PubMed ID: 20405912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization and in-vitro bioactivity evaluation of paclitaxel-loaded polyester nanoparticles.
    López-Gasco P; Iglesias I; Benedí J; Lozano R; Blanco MD
    Anticancer Drugs; 2012 Oct; 23(9):947-58. PubMed ID: 22713593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ester anhydride)/mPEG amphiphilic block co-polymer nanoparticles as delivery devices for paclitaxel.
    Liang Y; Xiao L; Li Y; Zhai Y; Xie C; Deng L; Dong A
    J Biomater Sci Polym Ed; 2011; 22(4-6):701-15. PubMed ID: 20566053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injectable self-assembled block copolymers for sustained gene and drug co-delivery: an in vitro study.
    Zhang B; Jia F; Fleming MQ; Mallapragada SK
    Int J Pharm; 2012 May; 427(1):88-96. PubMed ID: 22016031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.